Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Omicron Subvariants, Including BA.4 and BA.5, Substantially Preserve T Cell Epitopes of Ancestral SARS-CoV-2
Kyemyung Park, Seong Jin Choi, Eui‐Cheol Shin
Immune Network (2022) Vol. 22, Iss. 4
Open Access | Times Cited: 14
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents
Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022–2023 season dominated by Omicron BA.5 and BA.2 subvariants
Helena C. Maltezou, Maria N. Gamaletsou, Theodoros V. Giannouchos, et al.
Vaccine (2024) Vol. 42, Iss. 17, pp. 3693-3698
Closed Access | Times Cited: 2
Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature
Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou, et al.
Vaccines (2024) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 2
Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants
Manon Vogrig, Anne‐Emmanuelle Berger, Thomas Bourlet, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 1, pp. 31-45
Open Access | Times Cited: 9
Fully understanding the efficacy profile of the COVID-19 vaccination and its associated factors in multiple real-world settings
Yunes Panahi, Behzad Einollahi, Fatemeh Beiraghdar, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Comparing the immune response and protective effect of COVID-19 vaccine under different vaccination strategies
Tianyi Zhao, Xiaoping Huang, Yuelong Shu
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 4
Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents
Thanyawee Puthanakit, Napaporn Chantasrisawad, Kirana Yoohat, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1646-1646
Open Access | Times Cited: 7
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
Jie Bai, Asako Chiba, Goh Murayama, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients
Maria Antonella Zingaropoli, Mariasilvia Guardiani, Federica Dominelli, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 224-224
Open Access | Times Cited: 1
Impacts of delta and omicron variants on inactivated SARS‐CoV‐2 vaccine‐induced T cell responses in patients with autoimmune diseases and healthy controls
Shuyi Wang, Jin Li, Shuang Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
Roberto Alfonso, Jerry Lin, Joyce Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Omicron reactive multi protein specific CD4 T cells defines cellular immune response induced by inactivated virus vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
SARS-CoV-2 mRNA Vaccine Elicits Sustained T Cell Responses Against the Omicron Variant in Adolescents
Su-Jin Choi, Sang-Hoon Kim, Mi Seon Han, et al.
Immune Network (2023) Vol. 23, Iss. 4
Open Access | Times Cited: 2
Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)
Nancy Leung, Samuel M. S. Cheng, Carolyn A. Cohen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
Dongrong Yi, Yongxin Zhang, Jing Wang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 934-946
Open Access
SARS-CoV-2 vaccine-elicited immune responses in solid organ transplant recipients
Euri Seo, Eui‐Cheol Shin, Min Kyung Jung
Deleted Journal (2024) Vol. 38, Iss. 4, pp. 247-256
Open Access
Better understanding CD8+ T cells in cancer and viral infections
Hoyoung Lee, Min Kyung Jung, Ji Yun Noh, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1794-1796
Closed Access | Times Cited: 1
Association of Prior COVID-19 Infection with Risk of Breakthrough Infection Following Vaccination: A Cohort Study in Isfahan, Iran
Amirreza Manteghinejad, Sina Rasti, Maryam Nasirian, et al.
International Journal of Preventive Medicine (2024) Vol. 15
Open Access
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses
Rafael Bayarri‐Olmos, Adrian Sutta, Anne Rosbjerg, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Omicron Reactive Multi Protein Specific CD4 T Cells Defines Cellular Immune Response Induced by Inactivated Virus Vaccines
Joey Ming Er Lim, Shou Kit Hang, Smrithi Hariharaputran, et al.
SSRN Electronic Journal (2022)
Open Access | Times Cited: 2
Evaluation of Cellular Responses to ChAdOx1-nCoV-19 and BNT162b2 Vaccinations
Tae Hwan Lee, Minjeong Nam, Jong Do Seo, et al.
Annals of Laboratory Medicine (2022) Vol. 43, Iss. 3, pp. 290-294
Open Access | Times Cited: 2
Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after the third dose of BNT162b2 in healthy adolescents
YL Lau, Xiaofeng Mu, Carolyn A. Cohen, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
SARS-CoV-2-specific CD4+and CD8+T cell responses can originate from cross-reactive CMV-specific T cells
Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Humoral Immune Response of Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Prime-Boost Vaccination against SARS-CoV-2 Variants in Korea
Heeji Lim, Sundong Jang, Hyun Ju In, et al.
Infection and Chemotherapy (2023) Vol. 55, Iss. 1, pp. 99-99
Open Access

Scroll to top